Foundation Venture Capital Group

The firm sources exclusively from its affiliated research organizations — the New Jersey Health Foundation, the Foundation for Health Advancement, and their associated academic institutions. Startups are formed around intellectual property developed within that ecosystem, and Foundation Venture Capital Group gets a first look at pre-seed and seed-stage opportunities before any outside capital is involved.

Any realized gains are returned to the affiliated foundations — the New Jersey Health Foundation and the Foundation for Health Advancement — where they are reinvested into further research and innovation. This circular structure means the firm does not distribute profits to external LPs; the foundations themselves are the primary beneficiaries of the fund's financial success.

The firm typically provides the very first institutional capital — pre-seed and seed checks — and often acts as the sole institutional investor at formation. As portfolio companies mature, the team actively helps them secure follow-on funding from traditional venture firms; the $8 million Series A raised by Kayothera, led by Accelerator Life Science Partners, is a direct example of that handoff model.

Every disclosed investment is in health-related technology. The firm has no known positions in enterprise software, fintech, consumer internet, or deep tech outside of life sciences. Its mandate is explicitly tied to the health-research pipeline of its affiliated New Jersey institutions — sectors without a clear health application are not in scope.

The firm embeds strategic, operational, and back-office support from pre-incorporation through commercialization. According to its own description, that includes assistance with incorporation, business planning, IP strategy, and management recruiting — essentially acting as an operating partner until the startup can attract traditional venture funding.

President Jim Golubieski leads the firm, and his email is the primary contact listed on the website. The team page names eight professionals, though the firm does not publicly disclose a formal investment committee or detail decision-making authority among them. The small, foundation-integrated staff suggests centralization around Golubieski.

The firm is part of a family of companies alongside the New Jersey Health Foundation and the Foundation for Health Advancement. All three share the same Princeton office address, the same email domain (njhf.org), and the same core mission of advancing health-related innovation in New Jersey. Foundation Venture Capital Group serves as the investment arm that commercializes research funded by the other two entities.